×
About 12 results

NICE Draft Guidance Approves Fremanezumab for Chronic Migraine
https://www.medscape.com/viewarticle/926830

Mar 15th, 2020 - The National Institute for Health and Care Excellence (NICE) is set to approve a new prophylaxis treatment for migraine. Draft guidance published on 12th March 2020 recommends fremanezumab (Ajovy, Teva UK) as an option for preventing migraine in adults if: The migraine is chronic (≥15 headache days a month for more than three months with more than eight of those having features of migraine). Mo...

NICE Draft Guidance Approves Fremanezumab for Chronic Migraine
https://www.staging.medscape.com/viewarticle/926830

Mar 15th, 2020 - The National Institute for Health and Care Excellence (NICE) is set to approve a new prophylaxis treatment for migraine. Draft guidance published on 12th March 2020 recommends fremanezumab (Ajovy, Teva UK) as an option for preventing migraine in adults if: The migraine is chronic (≥15 headache days a month for more than three months with more than eight of those having features of migraine). Mo...

All Is Not Well in the World of Academic Scientific Enterprise
https://www.onclive.com/publications/oncology-live/2018/vol-19-no-9/all-is-not-well-in-the-world-of-academic-scientific-enterprise

Apr 27th, 2018 - Maurie Markman, MD It is quite difficult for those not directly involved in the complex world of academic medicine to understand fully the process of individual professional advancement and the values that organizations place on the components required for achieving and maintaining tenure. For that matter, the meaning of the term “tenure” is debated, and the implications of this status vary gre...

Do Online Medical Results Do More Harm Than Good?
https://www.medscape.com/viewarticle/894589

Mar 28th, 2018 - As she herded her two young sons into bed one evening late last December, Laura Devitt flipped through her phone to check on the routine blood tests that had been performed as part of her annual physical. She logged onto the patient portal link on her electronic medical record, scanned the results and felt her stomach clench with fear. Devitt’s white blood cell count and several other tests wer...

NIH Releases First Agency-Wide Strategic Plan to Enhance Health-Care Research and Technology
https://www.ashclinicalnews.org/news/nih-releases-first-agency-wide-strategic-plan-enhance-health-care-research-technology/

Feb 1st, 2016 - The NIH has released a five-year agency-wide strategic plan for expanding health-care research and technology, with specific goals to further explore HIV and influenza vaccines, cancer survival rates, and diabetes. This is the first effort from the agency to develop a plan that includes all 27 institutes and centers. In addition, the NIH included fiscal goals for 2016 through 2020. “Strategic a...

Oncology Enters the Informatics Era: Many Eager to Jump on the Health Information Highway
https://www.onclive.com/publications/obtn/2012/december-2012/oncology-enters-the-informatics-era-many-eager-to-jump-on-the-health-information-highway

Jan 14th, 2013 - Author: Ira M. Klein, MD, MBA Winston Churchill once said, “Americans can be counted on to do the right thing, once they’ve exhausted all other alternatives.” In our healthcare delivery system, we’ve embraced this principle through many false starts and unfulfilled promises in the fields of clinical informatics and integration. A few shining stars were mentioned in the recent presidential debat...

7 Questions... With Dr. Robert Kolodner
https://www.onclive.com/publications/oncology-live/2007/jan2007/ong_kolodner

Feb 24th, 2008 - 1. What major goals do you hope to achieve during your tenure, and which is the number one issue on your list? My goal during my tenure is to help move the health IT agenda from one phase to another. When David Brailer was here, he and his staff were setting up the Office of the National Coordinator for Health Information Technology and put a lot of effort into establishing a solid foundation. ...

What Can Healthcare Learn From Wall Street?
https://www.onclive.com/publications/oncology-live/2007/jun2007/onc-learnfrom

Feb 18th, 2008 - Prior to 2004, my exposure to information technology in healthcare had been limited to selling an early version of the Oracle database management system to a few hospitals. In 2004, our venture fund invested in a healthcare software company, RemedyMD, that was focused on helping providers and patients make better decisions. After a few weeks, the depth of the problem and the breadth of the oppo...

Who Will Change the Course of Health Information Technology?
https://www.onclive.com/publications/oncology-live/2007/jul2007/onc-changecourse

Feb 13th, 2008 - Health information technology (IT) is evolving rapidly. Big changes are on the way, including pay for performance (P4P), ePrescribing, ubiquitous electronic health records (EHRs), and computerized physician order entry (CPOE), interoperable patient data that can move from provider to provider effortlessly over high-speed Internet connections, and a new breed of personal health record that will ...

NICE Draft Guidance Approves Fremanezumab for Chronic Migraine
https://emedicine.medscape.com/viewarticle/926830

The National Institute for Health and Care Excellence (NICE) is set to approve a new prophylaxis treatment for migraine. Draft guidance published on 12th March 2020 recommends fremanezumab (Ajovy, Teva UK) as an option for preventing migraine in adults if: The migraine is chronic (≥15 headache days a month for more than three months with more than eight of those having features of migraine). Mo...

Do Online Medical Results Do More Harm Than Good?
https://emedicine.medscape.com/viewarticle/894589

As she herded her two young sons into bed one evening late last December, Laura Devitt flipped through her phone to check on the routine blood tests that had been performed as part of her annual physical. She logged onto the patient portal link on her electronic medical record, scanned the results and felt her stomach clench with fear. Devitt’s white blood cell count and several other tests wer...

Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel, Thwarting Novartis
https://emedicine.medscape.com/viewarticle/916700

(Reuters) - A U.S. judge on Friday said two patents relating to Amgen Inc's blockbuster rheumatoid arthritis drug Enbrel (etanercept) were valid, denying a challenge by Novartis AG, which is seeking to launch a copycat version. U.S. District Judge Claire Cecchi in Newark, New Jersey rejected arguments by Novartis' Sandoz unit that the patents covering Enbrel's active ingredient until 2029 shoul...